Break it Down: Orthocell’s Remplir builds strong US market momentum

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully looks at Orthocell (ASX:OCC), whose nerve repair product Remplir is continuing its strong US market momentum with increasing surgical adoption.

Watch the video to learn more.

While Orthocell is a Stockhead advertiser, it did not sponsor this content.